| Dr Robert B Constant, MD | |
|
3113 Lawton Rd, Suite 100, Orlando, FL 32803-3531 | |
| (407) 894-3241 | |
| (407) 896-9863 |
| Full Name | Dr Robert B Constant |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 3113 Lawton Rd, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124039458 | NPI | - | NPPES |
| 110044528 | Other | FL | RAILROAD MEDICARE |
| 043199100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | ME0043196 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert B Constant, MD 3113 Lawton Rd, Suite 100, Orlando, FL 32803-3531 Ph: (407) 894-3241 | Dr Robert B Constant, MD 3113 Lawton Rd, Suite 100, Orlando, FL 32803-3531 Ph: (407) 894-3241 |
News Archive
New research about the brain and related disorders will be unveiled at Neuroscience 2012 in New Orleans, Oct. 13-17. Findings will include how the brain weighs complex decisions; progress being made in treating Alzheimer's disease, spinal cord injury, and traumatic brain injury; and novel understanding of how life experiences, diet, and sleep influence brain health and wellness.
Scientists led by Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have discovered a gene signature biomarker that may predict which patients will respond - or not - to immune therapy.
Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.
› Verified 2 days ago
Vamsi Kiran Kodumuri, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 258 S Chickasaw Trl Ste 203, Orlando, FL 32825 Phone: 407-303-6588 | |
Francoeur Cadet, D.O Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 232 N Orange Blossom Trl, Orlando, FL 32805 Phone: 407-428-5751 Fax: 407-447-7245 | |
Andrija Vidic, D.O Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2415 N Orange Ave Ste 700, Orlando, FL 32804 Phone: 407-303-2474 Fax: 407-303-0680 | |
Azin Azarfar, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3400 Quadrangle Blvd, Orlando, FL 32817 Phone: 407-266-3627 Fax: 407-266-4911 | |
Zain Zamir, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2501 N Orange Ave Ste 235, Orlando, FL 32804 Phone: 407-303-7169 | |
Dr. Arsenio R Rodriguez, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1745 N Mills Avenue, Orlando, FL 32803 Phone: 407-841-7151 Fax: 407-648-2259 | |
Dr. Maria R Flores, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 70 W Gore St, Suite 100, Orlando, FL 32806 Phone: 407-426-8484 Fax: 404-426-8575 |